Mondritzki T, Mai TA, Vogel J, Pook E, et al. Cardiac output improvement by pecavaptan: A novel dual-acting vasopressin V1a/V2 receptor antagonist in experimental heart failure. Eur J Heart Fail 2020 Sep 18. doi: 10.1002/ejhf.2001.
PMID: 32946151